• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤坏死因子-α与表皮生长因子联合诱导SH-SY5Y神经母细胞瘤细胞发生肾上腺素能向间充质转分化。

Combination of tumor necrosis factor-α and epidermal growth factor induces the adrenergic-to-mesenchymal transdifferentiation in SH-SY5Y neuroblastoma cells.

作者信息

Huang Yue, Tsubota Shoma, Nishio Nobuhiro, Takahashi Yoshiyuki, Kadomatsu Kenji

机构信息

Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Department of Biochemistry, Nagoya University Graduate School of Medicine, Nagoya, Japan.

出版信息

Cancer Sci. 2021 Feb;112(2):715-724. doi: 10.1111/cas.14760. Epub 2020 Dec 21.

DOI:10.1111/cas.14760
PMID:33277754
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7893981/
Abstract

Neuroblastoma, a type of cancer that is common in children, is composed of two genetically clonal but epigenetically distinct cell types: mesenchymal (MES) and adrenergic (ADRN) types, controlled by super-enhancer-associated lineage-specific transcription factor networks. Mesenchymal-type cells are more migratory, resistant to chemotherapy, and prevalent in relapse tumors. Importantly, both cell types spontaneously transdifferentiate into one another, and this interconversion can be induced by genetic manipulations. However, the mechanisms of their spontaneous transdifferentiation and extracellular factors inducing this phenomenon have not yet been elucidated. Using a unique approach involving gene set enrichment analysis, we selected six ADRN and 10 MES candidate factors, possibly inducing ADRN and MES phenotypes, respectively. Treatment with a combination of 10 MES factors clearly induced the MES gene expression profile in ADRN-type SH-SY5Y neuroblastoma cells. Considering the effects on gene expression profile, migration ability, and chemoresistance, a combination of tumor necrosis factor alpha (TNF-α) and epidermal growth factor (EGF) was sufficient to synergistically induce the ADRN-to-MES transdifferentiation in SH-SY5Y cells. In addition, human neuroblastoma cohort analysis revealed that the expression of TNF and EGF receptors was strongly associated with MES gene expression signatures, supporting their important roles in transdifferentiation in vivo. Collectively, we propose a mechanism of neuroblastoma transdifferentiation induced by extracellular growth factors, which can be controlled in clinical situations, providing a new therapeutic possibility.

摘要

神经母细胞瘤是一种常见于儿童的癌症,由两种基因克隆但表观遗传不同的细胞类型组成:间充质(MES)型和肾上腺素能(ADRN)型,受超级增强子相关的谱系特异性转录因子网络控制。间充质型细胞迁移性更强,对化疗有抗性,且在复发性肿瘤中普遍存在。重要的是,这两种细胞类型会自发地相互转分化,并且这种相互转化可以通过基因操作来诱导。然而,它们自发转分化的机制以及诱导这种现象的细胞外因子尚未阐明。我们采用一种独特的方法,涉及基因集富集分析,分别选择了六个可能诱导ADRN表型和十个可能诱导MES表型的ADRN和MES候选因子。用10个MES因子的组合处理明显诱导了ADRN型SH-SY5Y神经母细胞瘤细胞中的MES基因表达谱。考虑到对基因表达谱、迁移能力和化疗抗性的影响,肿瘤坏死因子α(TNF-α)和表皮生长因子(EGF)的组合足以协同诱导SH-SY5Y细胞中ADRN向MES的转分化。此外,人类神经母细胞瘤队列分析显示,TNF和EGF受体的表达与MES基因表达特征密切相关,支持它们在体内转分化中的重要作用。总的来说,我们提出了一种由细胞外生长因子诱导的神经母细胞瘤转分化机制,这种机制在临床情况下可以得到控制,提供了一种新的治疗可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f77/7893981/bd52c7be1fdb/CAS-112-715-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f77/7893981/45c919939d39/CAS-112-715-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f77/7893981/7ee1bfcd8dc2/CAS-112-715-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f77/7893981/0550b8c68423/CAS-112-715-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f77/7893981/bd52c7be1fdb/CAS-112-715-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f77/7893981/45c919939d39/CAS-112-715-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f77/7893981/7ee1bfcd8dc2/CAS-112-715-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f77/7893981/0550b8c68423/CAS-112-715-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f77/7893981/bd52c7be1fdb/CAS-112-715-g004.jpg

相似文献

1
Combination of tumor necrosis factor-α and epidermal growth factor induces the adrenergic-to-mesenchymal transdifferentiation in SH-SY5Y neuroblastoma cells.肿瘤坏死因子-α与表皮生长因子联合诱导SH-SY5Y神经母细胞瘤细胞发生肾上腺素能向间充质转分化。
Cancer Sci. 2021 Feb;112(2):715-724. doi: 10.1111/cas.14760. Epub 2020 Dec 21.
2
A NOTCH feed-forward loop drives reprogramming from adrenergic to mesenchymal state in neuroblastoma.NOTCH 正向反馈环驱动神经母细胞瘤从肾上腺素能状态向间充质状态重编程。
Nat Commun. 2019 Apr 4;10(1):1530. doi: 10.1038/s41467-019-09470-w.
3
Characterizing Relationships between T-cell Inflammation and Outcomes in Patients with High-Risk Neuroblastoma According to Mesenchymal and Adrenergic Signatures.根据间充质和肾上腺素能特征,描述高危神经母细胞瘤患者 T 细胞炎症与结局的关系。
Cancer Res Commun. 2024 Aug 1;4(8):2255-2266. doi: 10.1158/2767-9764.CRC-24-0214.
4
Adrenergic and mesenchymal signatures are identifiable in cell-free DNA and correlate with metastatic disease burden in children with neuroblastoma.无肾上腺素能和间充质特征可在无细胞 DNA 中识别,并与神经母细胞瘤患儿的转移性疾病负担相关。
Pediatr Blood Cancer. 2024 Jan;71(1):e30735. doi: 10.1002/pbc.30735. Epub 2023 Oct 20.
5
Lineage-dependence of the neuroblastoma surfaceome defines tumor cell state-dependent and independent immunotherapeutic targets.神经母细胞瘤表面组的谱系依赖性定义了肿瘤细胞状态依赖性和非依赖性免疫治疗靶点。
bioRxiv. 2024 Jul 2:2024.06.27.600865. doi: 10.1101/2024.06.27.600865.
6
Adrenergic and mesenchymal signatures are identifiable in cell-free DNA and correlate with metastatic disease burden in children with neuroblastoma.在无细胞DNA中可识别出肾上腺素能和间充质特征,且这些特征与神经母细胞瘤患儿的转移性疾病负担相关。
bioRxiv. 2023 Sep 1:2023.08.30.554943. doi: 10.1101/2023.08.30.554943.
7
Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors.间质型神经母细胞瘤细胞逃避 ALK 抑制剂。
Cancer Res. 2022 Feb 1;82(3):484-496. doi: 10.1158/0008-5472.CAN-21-1621. Epub 2021 Dec 1.
8
Reciprocal impacts of telomerase activity and ADRN/MES differentiation state in neuroblastoma tumor biology.端粒酶活性和 ADRN/MES 分化状态在神经母细胞瘤肿瘤生物学中的相互影响。
Commun Biol. 2021 Nov 19;4(1):1315. doi: 10.1038/s42003-021-02821-8.
9
T-cell inflammation is prognostic of survival in patients with high-risk neuroblastoma enriched for an adrenergic signature.T细胞炎症对富含肾上腺素能特征的高危神经母细胞瘤患者的生存具有预后意义。
bioRxiv. 2023 Jun 28:2023.06.26.546541. doi: 10.1101/2023.06.26.546541.
10
Deep analysis of neuroblastoma core regulatory circuitries using online databases and integrated bioinformatics shows their pan-cancer roles as prognostic predictors.利用在线数据库和综合生物信息学对神经母细胞瘤核心调控通路进行深入分析,结果表明其作为预后预测指标具有泛癌作用。
Discov Oncol. 2021 Nov 29;12(1):56. doi: 10.1007/s12672-021-00452-3.

引用本文的文献

1
Identification and Characterization of Chemotherapy-Resistant High-Risk Neuroblastoma Persister Cells.化疗耐药高危神经母细胞瘤持久性细胞的鉴定与特征分析
Cancer Discov. 2024 Dec 2;14(12):2387-2406. doi: 10.1158/2159-8290.CD-24-0046.
2
Advancements of 3D bioprinting in regenerative medicine: Exploring cell sources for organ fabrication.3D生物打印在再生医学中的进展:探索用于器官制造的细胞来源。
Heliyon. 2024 Jan 17;10(3):e24593. doi: 10.1016/j.heliyon.2024.e24593. eCollection 2024 Feb 15.
3
Preclinical Models of Neuroblastoma-Current Status and Perspectives.

本文引用的文献

1
Pan-neuroblastoma analysis reveals age- and signature-associated driver alterations.全神经母细胞瘤分析揭示了与年龄和特征相关的驱动突变改变。
Nat Commun. 2020 Oct 14;11(1):5183. doi: 10.1038/s41467-020-18987-4.
2
ARID1A loss in neuroblastoma promotes the adrenergic-to-mesenchymal transition by regulating enhancer-mediated gene expression.神经母细胞瘤中ARID1A缺失通过调节增强子介导的基因表达促进肾上腺素能向间充质转变。
Sci Adv. 2020 Jul 15;6(29):eaaz3440. doi: 10.1126/sciadv.aaz3440. eCollection 2020 Jul.
3
A NOTCH feed-forward loop drives reprogramming from adrenergic to mesenchymal state in neuroblastoma.
神经母细胞瘤的临床前模型——现状与展望
Cancers (Basel). 2023 Jun 23;15(13):3314. doi: 10.3390/cancers15133314.
4
Reversible transitions between noradrenergic and mesenchymal tumor identities define cell plasticity in neuroblastoma.去甲肾上腺素能和间充质肿瘤表型之间的可逆转换定义了神经母细胞瘤中的细胞可塑性。
Nat Commun. 2023 May 4;14(1):2575. doi: 10.1038/s41467-023-38239-5.
5
Verteporfin-induced proteotoxicity impairs cell homeostasis and survival in neuroblastoma subtypes independent of YAP/TAZ expression.维替泊芬诱导的蛋白毒性损伤会破坏神经母细胞瘤亚型的细胞内稳态和存活,而与 YAP/TAZ 表达无关。
Sci Rep. 2023 Mar 7;13(1):3760. doi: 10.1038/s41598-023-29796-2.
6
Therapy resistance in neuroblastoma: Mechanisms and reversal strategies.神经母细胞瘤中的治疗抵抗:机制与逆转策略。
Front Pharmacol. 2023 Feb 16;14:1114295. doi: 10.3389/fphar.2023.1114295. eCollection 2023.
7
Neuroprotective effect of phospholipase A from Malaysian venom against HO-induced cell damage and apoptosis.马来西亚毒液中磷脂酶A对过氧化氢诱导的细胞损伤和凋亡的神经保护作用。
Front Pharmacol. 2022 Oct 14;13:935418. doi: 10.3389/fphar.2022.935418. eCollection 2022.
8
tumors, but not tumor-derived cell lines, are adrenergic lineage, GD2+, and responsive to anti-GD2 antibody therapy.肿瘤而非肿瘤衍生细胞系具有肾上腺素能谱系特征,GD2+,并且对抗 GD2 抗体治疗有反应。
Oncoimmunology. 2022 May 24;11(1):2075204. doi: 10.1080/2162402X.2022.2075204. eCollection 2022.
NOTCH 正向反馈环驱动神经母细胞瘤从肾上腺素能状态向间充质状态重编程。
Nat Commun. 2019 Apr 4;10(1):1530. doi: 10.1038/s41467-019-09470-w.
4
A mechanistic classification of clinical phenotypes in neuroblastoma.神经母细胞瘤临床表型的机制分类。
Science. 2018 Dec 7;362(6419):1165-1170. doi: 10.1126/science.aat6768.
5
Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries.神经母细胞瘤细胞身份的异质性由转录电路定义。
Nat Genet. 2017 Sep;49(9):1408-1413. doi: 10.1038/ng.3921. Epub 2017 Jul 24.
6
Neuroblastoma is composed of two super-enhancer-associated differentiation states.神经母细胞瘤由两种与超级增强子相关的分化状态组成。
Nat Genet. 2017 Aug;49(8):1261-1266. doi: 10.1038/ng.3899. Epub 2017 Jun 26.
7
Neuroblastoma.神经母细胞瘤。
Nat Rev Dis Primers. 2016 Nov 10;2:16078. doi: 10.1038/nrdp.2016.78.
8
The development of cisplatin resistance in neuroblastoma is accompanied by epithelial to mesenchymal transition in vitro.顺铂耐药性在神经母细胞瘤中的发展伴随着体外上皮间质转化。
Cancer Lett. 2015 Aug 10;364(2):142-55. doi: 10.1016/j.canlet.2015.05.004. Epub 2015 May 7.
9
The causes and consequences of genetic heterogeneity in cancer evolution.癌症进化中遗传异质性的原因和后果。
Nature. 2013 Sep 19;501(7467):338-45. doi: 10.1038/nature12625.
10
A NOTCH3 transcriptional module induces cell motility in neuroblastoma.一个 NOTCH3 转录模块诱导神经母细胞瘤中的细胞迁移。
Clin Cancer Res. 2013 Jul 1;19(13):3485-94. doi: 10.1158/1078-0432.CCR-12-3021. Epub 2013 May 6.